Keywords: Merck & Co, Juvisnyc, Januvia, Zocor, Type 2 diabetes, Statin therapy, USA, FDA

FDA clears Merck & Co’s combo diabetes/cholesterol therapy Juvisync

Article | 10 October 2011

Print This

The US Food and Drug Administration on Friday approved the marketing of the first combination drug to treat type 2 diabetes ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in